{"links":{"feed":"https://www.erudio.com/reports/amplify-7p-nct05726864/feed.json","html":"https://www.erudio.com/reports/amplify-7p-nct05726864","json":"https://www.erudio.com/reports/amplify-7p-nct05726864.json","markdown":"https://www.erudio.com/reports/amplify-7p-nct05726864.md","mcp":{"server":"https://mcp.erudio.com/free","tool":"get_report_card","arguments":{"slug":"amplify-7p-05726864"}},"request":"https://www.erudio.com/contact?report=amplify-7p-05726864"},"offer":{"cited_clinicians":10,"cited_commentary_sources":75,"verified_hcp_statements":255,"currency":"USD","delivery":{"checkout":"online","current_edition":"Emailed as soon as payment clears: downloads, a license key and a prompt that connects your AI agent through Erudio MCP. One key per email address holds every report bought with it.","refresh":"A purchase starts a check for new commentary. A new edition, if one results, is sent to the buyer at no charge."},"identities":{"adds":"Verified speaker identities: the verified IDs of the people in the report, led by the NPI or their institution's staff page, so a Medical Affairs team can check that each statement is attributed to the right person: also X, Bluesky, LinkedIn and other web pages, ORCID and OpenAlex where verified, inline on each person card (identifiers.status included). Without the add-on, each card's identifiers.status says whether the person is verified. For checking attribution inside the organization; never for outreach to or targeting of clinicians. Every report already names and describes its speakers and includes CMS-reported financial relationships. Sample: https://www.erudio.com/report-sample.json","available_with":"12-month updates","cap_usd":1250,"identity_verified_people":17,"optional":true,"price_per_verified_person_usd":15,"price_usd":255,"product":"updates-12-identities","terms":"Priced on the identity-verified people in the edition at purchase; people verified later in the term come at no charge."},"one_off_usd":1250,"purchase":{"agents":{"free_mcp":"https://mcp.erudio.com/free","keys":"One license key holds every report: get_order returns it once paid (store it as a secret), send it as licence_key with every later create_order so new reports join it. The buyer gets their account key by email, which reads every report bought with their address; recover_key (POST /api/keys/recover) with the buyer's email sends it again.","mcp_flow":["1. search_reports: Find reports by trial, NCT ID, drug, indication or sponsor. Each result has its page URL and price.","2. get_report_card: Preview one report with the slug from search_reports: what it covers, its findings and limits, and the price of each product.","3. create_order: Order the current edition or 3, 6 or 12 months of updates for your person. It returns the quote, a checkout_url for your person to pay by card and, when offered, a pay_url your own payment client can pay over HTTP 402 (MPP or x402). Nothing is charged until one is paid.","4. get_order: Once the order is paid, it returns the license key. Store the key as a secret and send it as licence_key with every later create_order, so one key holds every report.","5. read_report: Read the report in full or by section on https://mcp.erudio.com/mcp, with the key as Authorization: Bearer. get_report_changes shows what a newer edition changed."],"order_endpoint":"https://www.erudio.com/api/orders","order_request":{"buyer_email":"name@company.com","idempotency_key":"optional, one per purchase","licence_key":"optional: your key from an earlier purchase","organization":"optional","product":["edition","updates-3","updates-6","updates-12","updates-12-identities"],"report":"amplify-7p-nct05726864"},"steps":"Create the order (with licence_key if you hold one) and show checkout_url to your person to pay by card. If the order also returns pay_url, you can pay it yourself instead: POST pay_url answers 402 Payment Required with MPP or x402 offers for your payment client. Once paid, status_url (or get_order) returns the license key, the MCP setup and downloads."},"contact":{"email":"hello@erudio.com","form":"https://www.erudio.com/contact?report=amplify-7p-05726864","people":"Audun Utengen and Tom Lee, the founders","use_for":"Questions, invoices, purchase orders"},"methods":["card (Stripe Checkout)"],"people":"https://www.erudio.com/reports/amplify-7p-nct05726864","renewal":"Subscriptions are prepaid and do not renew automatically.","upgrades":"What the buyer already paid on this trial counts toward a longer plan: a one-off edition within 30 days, or an active plan at any time in its term. The buyer pays the difference; an upgraded plan keeps its original start, and an upgraded one-off starts the plan on payment. Order the longer product with create_order and the buyer's licence_key (or on the report page with the buyer's email); the quote shows the credit.","terms":"https://www.erudio.com/terms"},"size":"standard","size_line":"Standard · 255 verified statements · 51 from 10 confirmed clinicians","size_rule":"Standard: 151–300 verified statements. Standard and Deep need at least 5 confirmed clinicians cited (role verified by the NPI registry or their own institution's staff page); with fewer, a report is sold one size down.","updates_usd":{"3_months":2200,"6_months":3100,"12_months":4400},"volume_discounts":[{"min_subscribed_trials":10,"percent_off_updates":25},{"min_subscribed_trials":5,"percent_off_updates":15}]},"publication_state":"public","record":{"change":{"changed_finding_ids":{"reason":"No changed finding IDs recorded.","status":"none"},"last_checked_at":"2026-11-04T17:45:51.047983Z","notify_subscribers":false,"status":"new","summary":{"reason":"First accepted edition: there is no earlier edition to compare.","status":"not_applicable"}},"contents":{"aspect_coverage":{"assessment_incomplete":0,"discussed":18,"no_commentary_found":0},"aspects":[{"claim_count":1,"coverage":"discussed","id":"T1","registry_field":"outcomesModule.primaryOutcomes[0]","source_count":1,"title":"Primary endpoint: Phase 1: Evaluate the safety of ELI-002 7P"},{"claim_count":13,"coverage":"discussed","id":"T2","registry_field":"outcomesModule.primaryOutcomes[1]","source_count":12,"title":"Primary endpoint: Phase 2: Compare ELI-002 7P versus standard of care (SOC; observation) in DFS (disease free survival)"},{"claim_count":4,"coverage":"discussed","id":"T3","registry_field":"outcomesModule.secondaryOutcomes[0]","source_count":4,"title":"Secondary endpoint: Phase 2: Overall Survival (OS)"},{"claim_count":1,"coverage":"discussed","id":"T4","registry_field":"outcomesModule.secondaryOutcomes[1]","source_count":1,"title":"Secondary endpoint: Phase 1 and Phase 2: Determine the biomarker reduction or clearance rate"},{"claim_count":1,"coverage":"discussed","id":"T5","registry_field":"outcomesModule.secondaryOutcomes[2]","source_count":1,"title":"Secondary endpoint: Phase 2: Determine the 1-year DFS"},{"claim_count":4,"coverage":"discussed","id":"T6","registry_field":"outcomesModule.secondaryOutcomes[3]","source_count":4,"title":"Secondary endpoint: Phase 2: Evaluate the safety of ELI-002 7P"},{"claim_count":9,"coverage":"discussed","id":"T7","registry_field":"conditionsModule","source_count":7,"title":"Population and setting"},{"claim_count":5,"coverage":"discussed","id":"T8","registry_field":"armsInterventionsModule.armGroups","source_count":4,"title":"The comparison"},{"claim_count":6,"coverage":"discussed","id":"T9","registry_field":"outcomesModule","source_count":6,"title":"Safety and tolerability"},{"claim_count":9,"coverage":"discussed","id":"T10","registry_field":"designModule","source_count":4,"title":"Design and conduct"},{"claim_count":17,"coverage":"discussed","id":"A1","source_count":12,"title":"Immune activation versus demonstrated clinical benefit"},{"claim_count":16,"coverage":"discussed","id":"A2","source_count":11,"title":"R0/R1 imbalance and credibility of an R0-focused strategy"},{"claim_count":18,"coverage":"discussed","id":"A3","source_count":10,"title":"ctDNA, residual disease and prior radiation as prognostic or selection factors"},{"claim_count":27,"coverage":"discussed","id":"A4","source_count":18,"title":"Durability, extended dosing, combinations and phase 3 readiness"},{"claim_count":19,"coverage":"discussed","id":"A5","source_count":13,"title":"Off-the-shelf versus personalized platforms, HLA breadth and equitable research access"},{"claim_count":26,"coverage":"discussed","id":"A6","source_count":9,"title":"AMPLIFY-201 ELI-002 2P as the rationale for expectations about ELI-002 7P"},{"claim_count":18,"coverage":"discussed","id":"A7","source_count":10,"title":"Event-driven timing, external control expectations and failed forecasts"},{"claim_count":15,"coverage":"discussed","id":"A8","source_count":7,"title":"Patient hope, research participation and communication about cure or standard care"}],"counts":{"cited_clinicians":10,"cited_clinicians_by_role":{"physician":1,"physician, Hematology and oncology":1,"physician, Medical oncology":7,"physician, Pathology":1},"cited_physicians":10,"cited_sources":77,"claims_by_expression_type":{"comparison":14,"experience":5,"interpretation":90,"opinion":50,"primary_context":3,"question":18,"restatement":37,"uncertainty":9,"unspecified":29},"claims_by_kind":{"interpretation":2,"protocol_statement":2,"publication_statement":1,"source_observation":250},"clinician_statements":51,"evidence_units":154,"findings":10,"organisational_accounts":18,"people_cited":32,"people_identity_verified":17,"people_total":32,"screened_sources":228,"verified_claims":255},"findings_index":[{"id":"F1","structure":{"claims":13,"claims_by_group":{"comparisons":0,"experience":0,"questions":1,"restated":1,"views":11},"limitations":3,"links":{"context":0,"support":13},"ma_question":true,"named_voices":7,"passages":8,"sources":8,"sources_by_kind":{"commentary":8}},"title":"Speakers weigh AMPLIFY-7P’s immune-response findings and research prospects despite missed primary DFS endpoint and unproven clinical benefit; one poster rejects softening trial failure."},{"id":"F2","structure":{"claims":18,"claims_by_group":{"comparisons":0,"experience":0,"questions":3,"restated":1,"views":14},"limitations":3,"links":{"context":0,"support":21},"ma_question":true,"named_voices":10,"passages":11,"sources":11,"sources_by_kind":{"commentary":10,"media":1}},"title":"Speakers see an R0 development rationale, while others question whether the subgroup can support a confirmatory program"},{"id":"F3","structure":{"claims":20,"claims_by_group":{"comparisons":1,"experience":0,"questions":7,"restated":1,"views":11},"limitations":3,"links":{"context":0,"support":21},"ma_question":true,"named_voices":8,"passages":11,"sources":10,"sources_by_kind":{"commentary":9,"media":1}},"title":"Speakers treat ctDNA and prior radiation as selection hypotheses; one public explainer presents them much more decisively"},{"id":"F4","structure":{"claims":9,"claims_by_group":{"comparisons":0,"experience":0,"questions":2,"restated":2,"views":5},"limitations":3,"links":{"context":0,"support":9},"ma_question":true,"named_voices":7,"passages":9,"sources":8,"sources_by_kind":{"commentary":5,"media":2,"publication":1}},"title":"Speakers welcome tolerability but do not regard it as a substitute for efficacy; one asks about anti-albumin immunity"},{"id":"F5","structure":{"claims":26,"claims_by_group":{"comparisons":0,"experience":1,"questions":4,"restated":9,"views":12},"limitations":5,"links":{"context":2,"support":29},"ma_question":true,"named_voices":18,"passages":18,"sources":17,"sources_by_kind":{"commentary":15,"media":2}},"title":"Speakers favor further development; one poster questions whether uncontrolled metastatic ORR can isolate added vaccine activity"},{"id":"F6","structure":{"claims":19,"claims_by_group":{"comparisons":3,"experience":0,"questions":1,"restated":5,"views":10},"limitations":4,"links":{"context":3,"support":22},"ma_question":true,"named_voices":10,"passages":20,"sources":13,"sources_by_kind":{"commentary":10,"media":2,"registry":1}},"title":"Speakers value off-the-shelf breadth and access, while one questions whether a neoantigen-based vaccine may be better"},{"id":"F7","structure":{"claims":28,"claims_by_group":{"comparisons":1,"experience":0,"questions":2,"restated":7,"views":18},"limitations":4,"links":{"context":7,"support":30},"ma_question":true,"named_voices":9,"passages":19,"sources":9,"sources_by_kind":{"commentary":6,"media":3}},"title":"Speakers use AMPLIFY-201 to explain vaccine enthusiasm while acknowledging that responder comparisons do not establish efficacy"},{"id":"F8","structure":{"claims":19,"claims_by_group":{"comparisons":2,"experience":2,"questions":2,"restated":3,"views":10},"limitations":3,"links":{"context":1,"support":20},"ma_question":true,"named_voices":5,"passages":15,"sources":11,"sources_by_kind":{"commentary":11}},"title":"Public commentators disagree on what delayed DFS maturation implies, and one explicitly acknowledges a failed efficacy prediction"},{"id":"F9","structure":{"claims":14,"claims_by_group":{"comparisons":0,"experience":2,"questions":0,"restated":1,"views":11},"limitations":3,"links":{"context":2,"support":17},"ma_question":true,"named_voices":6,"passages":9,"sources":6,"sources_by_kind":{"commentary":4,"media":2}},"title":"One clinician describes trial participation as a source of hope; public commentators warn that immune response is not cure"},{"id":"F_C4_metastatic_combination_context","structure":{"claims":4,"claims_by_group":{"comparisons":0,"experience":0,"questions":0,"restated":3,"views":1},"limitations":3,"links":{"context":0,"support":5},"ma_question":true,"named_voices":2,"passages":2,"sources":2,"sources_by_kind":{"commentary":2}},"title":"One author reads metastatic sequential responses as encouragement for combinations; one poster questions what uncontrolled ORR can attribute to vaccination"}],"medical_affairs_question":"What prospective evidence would justify adding vaccination after standard care, distinguish its contribution within combinations, and explain uncertainty without extinguishing hope?","sections":{"analysis":[{"id":"section-1","level":2,"title":"Immune activity is not the clinical outcome speakers require"},{"id":"section-2","level":2,"title":"Margin status offers a phase 3 hypothesis, not a settled explanation"},{"id":"section-3","level":2,"title":"ctDNA and radiation raise prognostic, predictive and statistical questions"},{"id":"section-4","level":2,"title":"Tolerability is welcomed, but the comparator changes its meaning"},{"id":"section-5","level":2,"title":"Further development is supported, but regimen and readiness remain contested"},{"id":"section-6","level":2,"title":"Platform breadth and access compete with personalization questions"},{"id":"section-7","level":2,"title":"AMPLIFY-201 explains enthusiasm but does not answer AMPLIFY-7P's randomized question"},{"id":"section-8","level":2,"title":"Readout timing generated forecasts, not a reliable efficacy surrogate"},{"id":"section-9","level":2,"title":"Hope supports participation, not a cure claim"},{"id":"section-10","level":2,"title":"Scope and coverage"},{"id":"section-11","level":2,"title":"Scope and coverage"}],"executive_summary":{"reason":"Reviewed narrative has no headings.","status":"unavailable"}},"study_design":"interventional, randomized, sequential, phase1, phase2","trial_dimensions":[{"findings":[],"id":"T1","label":"Primary endpoint: Phase 1: Evaluate the safety of ELI-002 7P"},{"findings":[{"id":"F1","shared_claims":7},{"id":"F2","shared_claims":1},{"id":"F4","shared_claims":1},{"id":"F5","shared_claims":1}],"id":"T2","label":"Primary endpoint: Phase 2: Compare ELI-002 7P versus standard of care (SOC; observation) in DFS (disease free survival)"},{"findings":[{"id":"F1","shared_claims":1},{"id":"F5","shared_claims":1},{"id":"F9","shared_claims":2}],"id":"T3","label":"Secondary endpoint: Phase 2: Overall Survival (OS)"},{"findings":[],"id":"T4","label":"Secondary endpoint: Phase 1 and Phase 2: Determine the biomarker reduction or clearance rate"},{"findings":[{"id":"F5","shared_claims":1}],"id":"T5","label":"Secondary endpoint: Phase 2: Determine the 1-year DFS"},{"findings":[{"id":"F1","shared_claims":1},{"id":"F4","shared_claims":3}],"id":"T6","label":"Secondary endpoint: Phase 2: Evaluate the safety of ELI-002 7P"},{"findings":[{"id":"F1","shared_claims":1},{"id":"F3","shared_claims":3},{"id":"F6","shared_claims":4},{"id":"F9","shared_claims":1}],"id":"T7","label":"Population and setting"},{"findings":[{"id":"F4","shared_claims":2},{"id":"F5","shared_claims":1},{"id":"F7","shared_claims":1},{"id":"F9","shared_claims":1}],"id":"T8","label":"The comparison"},{"findings":[{"id":"F4","shared_claims":6}],"id":"T9","label":"Safety and tolerability"},{"findings":[{"id":"F2","shared_claims":4},{"id":"F3","shared_claims":5},{"id":"F8","shared_claims":1}],"id":"T10","label":"Design and conduct"}]},"identity":{"accepted_at":"2026-11-04T17:45:51.047983Z","edition_number":1,"previous_run_id":{"reason":"First accepted catalog edition.","status":"not_applicable"},"previous_version":{"reason":"First accepted catalog edition.","status":"not_applicable"},"product_contract":"hcp-commentary-1","published_at":"2026-11-04T17:59:27Z","record_hash":"ee2f5d11769f3f5889f62b3910d94d62e7b8ea684e5ac3768e87f7704bd6f17c","release_hash":"6995ea73ba328a08dcda2cce1355a082e9b77bbc9e8a9b39768137d70513e735","report_id":"erudio-nct05726864","run_id":"63dd6567-20dd-4ec4-a539-31d69286468c","schema_version":"5.0","slug":"amplify-7p-05726864","version":"1.0.0","version_reason":"initial"},"offer":{"bundle_eligible":{"reason":"Owner has not set bundle_eligible.","status":"not_set"},"license_ref":{"reason":"Owner has not set license_ref.","status":"not_set"},"request_route":{"reason":"Owner has not set request_route.","status":"not_set"},"single_edition":{"reason":"Owner has not set single_edition.","status":"not_set"},"updates":{"reason":"Owner has not set updates.","status":"not_set"}},"preview":{"abstract":"AMPLIFY-7P tests ELI-002 7P against observation for disease-free survival in KRAS/NRAS-mutated pancreatic ductal adenocarcinoma; debate weighs immune activity against a negative clinical result. The report cites 10 physicians, including seven medical oncologists and a physician described in the sources as involved in AMPLIFY-7P; a medical oncologist recalls having the trial open at their center. R0-focused development and ctDNA-guided patient selection remain debated. What future trials would justify adding vaccination after standard care, isolate its contribution in combinations and help explain uncertainty without taking away hope?","meta_description":"228 sources screened · 255 verified statements (51 from clinicians verified by NPI or staff page) from 77 sources · 10 findings. Updated Nov 4, 2026.","person_names_policy":"role_only","sample_findings":[]},"publication":{"approved_at":"2026-11-04T17:59:27Z","approved_by":"Erudio publisher","corrections":[],"rights_status":"cleared: short attributed excerpts with link-out; no-derivatives sources suppressed; role-only names in previews","state":"public"},"schema_id":"erudio.catalog_record","schema_version":"2.1","scope_and_limits":{"commentary_scope":{"basis":"Only the sources used in this report; not all HCPs or all public discussion.","has_known_gaps":true,"source_count":228},"does_not":["judge efficacy","estimate HCP prevalence or consensus","give treatment advice"],"known_gaps":["Discussion that does not name the trial may be missing from this edition.","3 matching sources (2 X threads, 1 YouTube video) could not be read and are not included.","1 cited commentary passage leaves a source question open, such as who was speaking. The report attributes no further than the source shows.","Not yet captured in this edition: a remark on an unspecified anticipated milestone for vaccination after curative-intent therapy.","116 passages in 71 sources used in this report were not fully assessed for clinician views, so a view there may be missing from this edition.","145 statements in the sources reviewed for this edition are about other patients or topics, or only mention the trial, and are not counted.","Further source limits: discussion that describes the trial without naming it may be incomplete; some discussion that describes the trial without naming it may be missing; 7 sources about other trials or topics are not included.","The sources reviewed for this edition are not representative of all HCPs or all public discussion. Repeated posts and reposts should not be counted as independent clinical agreement.","Several audio and video statements cannot be assigned to a named speaker. A program description, channel name or guest list does not identify who said a particular passage.","Named authors and account operators have differing levels of identity and professional-role confirmation. Patient, corporate and investment perspectives are not treated as confirmed HCP views.","No full protocol or exact regulatory label was available. The report cannot independently settle statistical-analysis planning, regulatory requirements or approved-use status.","The R0 analysis is described inconsistently as post hoc or prespecified, and phase 3 is described inconsistently as ongoing, planned or possible. These accounts are preserved rather than reconciled by assumption.","Immune-response findings use evaluable-patient denominators and response-defined associations. They do not establish recurrence prevention, survival benefit or cure in the full randomized population.","Earlier AMPLIFY-201 ELI-002 2P findings, historical comparisons and model-based timing arguments provide context for expectations, not randomized AMPLIFY-7P efficacy evidence.","The report does not treat proposed longer dosing, checkpoint combinations, molecular enrichment or off-the-shelf access advantages as demonstrated clinical benefits.","The three-patient metastatic observations after ELI-002 7P and later nivolumab-based therapy explain interest in combination research. They do not answer the postoperative randomized question or establish concurrent-combination efficacy.","Coverage of alternative postoperative vaccine studies is incomplete, particularly their chemotherapy backbones, comparators, accrual status and time to randomized evidence. The report should not be read as a complete comparison of those alternatives."]},"sources":{"cited_sources":{"by_channel":{"bluesky_thread":3,"linkedin_post":7,"other":0,"podcast":3,"publication":1,"registry":1,"regulatory":0,"x_thread":57,"x_video":0,"youtube":5},"by_evidence_role":{"commentary":75,"context":1,"methods":1},"count":77,"evidence_window":{"end":"2026-11-03","start":"2024-01-09"},"retrieval_snapshot":"2026-11-04T15:26:26.195797Z","timeline":[{"count":1,"week":"2024-W02"},{"count":1,"week":"2024-W03"},{"count":1,"week":"2024-W04"},{"count":1,"week":"2024-W06"},{"count":1,"week":"2024-W07"},{"count":1,"week":"2024-W24"},{"count":1,"week":"2025-W32"},{"count":2,"week":"2025-W33"},{"count":1,"week":"2025-W38"},{"count":1,"week":"2025-W40"},{"count":1,"week":"2025-W41"},{"count":4,"week":"2025-W44"},{"count":2,"week":"2025-W45"},{"count":1,"week":"2026-W05"},{"count":1,"week":"2026-W07"},{"count":1,"week":"2026-W09"},{"count":1,"week":"2026-W10"},{"count":1,"week":"2026-W12"},{"count":1,"week":"2026-W14"},{"count":1,"week":"2026-W18"},{"count":1,"week":"2026-W20"},{"count":1,"week":"2026-W22"},{"count":12,"week":"2026-W25"},{"count":2,"week":"2026-W26"},{"count":1,"week":"2026-W27"},{"count":1,"week":"2026-W30"},{"count":2,"week":"2026-W31"},{"count":1,"week":"2026-W40"},{"count":3,"week":"2026-W42"},{"count":21,"week":"2026-W43"},{"count":8,"week":"2026-W44"},{"count":1,"week":"2026-W45"}],"undated_sources":2},"quote_policies":[{"id":"clinicaltrials:NCT05726864:methods","quote_policy":"short_quote_link_out"},{"id":"clinicaltrials:NCT05726864:context","quote_policy":"short_quote_link_out"},{"id":"pubmed:42919966","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-2ldgzgkb5gn7kfn35avzn7ai-3modf4yhptk2j","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-2ldgzgkb5gn7kfn35avzn7ai-3moibog445u2l","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-47eyg4sm7lvqbke5glkahofa-3myk7wkafx22k","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-4jxwbiximxdtavgw33mgwfhx-3modzkacgud2y","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-ffhfzwr3igtwt4y7zdompvjv-3lcfloz5nt52z","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-ffhfzwr3igtwt4y7zdompvjv-3lvnkkv5v732m","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-ffhfzwr3igtwt4y7zdompvjv-3lyzrxqble427","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-ffhfzwr3igtwt4y7zdompvjv-3m46emqtq562w","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-ffhfzwr3igtwt4y7zdompvjv-3m7pmxczpyd2d","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-ffhfzwr3igtwt4y7zdompvjv-3mod4xt7m662p","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-ffhfzwr3igtwt4y7zdompvjv-3moibaxvpin2p","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-ffhfzwr3igtwt4y7zdompvjv-3mykac2ywii2y","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-ffhfzwr3igtwt4y7zdompvjv-3myzd3lxkdk2m","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-kaw4dwcvhf6s66zt7qqx6daq-3mz47y7epik22","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-kwntu4mgap2otpkyzq5bchim-3m46fa26egr2g","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-kwntu4mgap2otpkyzq5bchim-3m52bnivaqy2n","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-kwntu4mgap2otpkyzq5bchim-3mod63teumr2v","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-kwntu4mgap2otpkyzq5bchim-3mwbakfi47y2l","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-kwntu4mgap2otpkyzq5bchim-3mykbgw23ca2u","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-lc6hdhnjkgccd6ysi7e23pll-3mykv76foys2m","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-ngdd6z6ozqhwlbeckdzwirp7-3modeuqezg22n","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-qfkt3i5kooppuue5onesacut-3mynnb3vaz22b","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-t5kvjzece3qgysdmwvem36xv-3mykc2ikqrs2h","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-tw3hsl5webkeb6flocjlqcwl-3myxuotdgsk2y","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-v2bbfxjs2fopw6y76ibai2cd-3mymyxs6yri2k","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-vlbpdban632brzgecx2wjol2-3mz3g5doz3w25","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-zwaxkm7x44me7z7nwpagim42-3myhfs6b3dr2k","quote_policy":"short_quote_link_out"},{"id":"mcp:bluesky_thread:plc-zxysncm7uct2urrgikjjx445-3lw7lr365e22c","quote_policy":"short_quote_link_out"},{"id":"mcp:linkedin_post:7474735166486122498","quote_policy":"short_quote_link_out"},{"id":"mcp:linkedin_post:7477691059599216640","quote_policy":"short_quote_link_out"},{"id":"mcp:linkedin_post:7517067922444271616","quote_policy":"short_quote_link_out"},{"id":"mcp:linkedin_post:7519380918793424896","quote_policy":"short_quote_link_out"},{"id":"mcp:linkedin_post:7519439485147938816","quote_policy":"short_quote_link_out"},{"id":"mcp:linkedin_post:7519457735525150720","quote_policy":"short_quote_link_out"},{"id":"mcp:linkedin_post:7520949306502131712","quote_policy":"short_quote_link_out"},{"id":"mcp:linkedin_post:7521179685930622976","quote_policy":"short_quote_link_out"},{"id":"mcp:podcast:2e0b0f","quote_policy":"short_quote_link_out"},{"id":"mcp:podcast:338058","quote_policy":"short_quote_link_out"},{"id":"mcp:podcast:73dfb9","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1651647588611792902:2d89997d-8f94-49b3-8d10-04628ab6cf5d","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1651913537373995010:23e728db-294c-4c6d-a2d8-968a5cf12628","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1744700876999053475:f52d62bd-3c27-45fe-8c93-fe02b69b42c8","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1745450018772050071:65f1e8c4-0619-443c-968e-7bb53519e01b","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1745494547134640563:4904e45c-f334-44ef-a6b3-916aab476eae","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1745868337899253857:e8e5178c-596e-460c-9fd0-afcab5c915fc","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1747622420804960324:e50b2f0d-f8a8-45a3-a3f7-b295a2ba46dd","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1747626940406677648:76e4140c-f763-4b11-b890-3df7b22d333d","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1747627455458795822:83e757c3-51b5-48b2-a2b4-882b910e4779","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1747649009383268762:5c5e33ed-0d8d-4e43-98d8-49573100b3ee","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1756058289803035090:5bd6020a-b615-4ae7-9556-ee133314ca4f","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1757057351960481939:fd441302-5286-4b9c-9ea9-4275c2b6941a","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1783474046639690233:3064e032-d22e-495a-8743-cf4343a43136","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1783477880107962413:470aa0cc-caed-48ed-bea0-7a86f249d950","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1783481608512942406:406ade86-70d9-4e48-a0cd-500e34964ccd","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1783482341832188234:be3eabad-80df-4bf8-bae2-8fa4f9bdb425","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1783501875767382383:eb550675-afeb-4761-8ba5-7efd0f86b79d","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1783557620218892463:60c112a0-b304-42b1-b937-e98074357aef","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1783859981973856686:e6d85b8a-dfc4-4094-9826-56ee75e807e5","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1787933276029538636:19d60dd6-c62b-423e-82a8-23e3207dd873","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1793756809469055103:0c51250f-b7af-47de-8eee-541b1582a1ab","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1793786094561206355:afb21c9d-7705-4b64-9a26-8938b81c7df5","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1793838099325468792:1fbdb36a-a3a2-4f1e-874f-6d96bc0a1ce9","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1793924658208600417:cea8b4a5-1b16-4cb8-b072-4dccabd159b4","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1793991368370508268:0758b018-1d85-45c1-83df-5345b4c1e423","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1794050210945028181:1220323f-c522-435d-b6b0-abee99b4e4d9","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1800981903727632747:76c9b41d-61e9-4b57-9753-c63e56ab39e8","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1805768005806182617:fafa2697-205b-4b9d-9cb1-a2e155b3bcba","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1806418239032897757:52c7fd32-7e68-4c8d-95fa-2fe01774b4a8","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1806425292766122412:31869e13-ae36-468e-ac48-570c5b44cc59","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1806426983917924841:ebcd12f0-0cb9-4505-b103-96b0e4b04a82","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1806670139938492649:9115e64d-e5d3-4e50-8a8b-41093e6c5f9d","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1854637011463811259:9ab80094-24ae-4b4b-bb4e-eae600943eea","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1854638029669122364:873cfc5c-d3a6-483c-9e9d-9c1c72f58d5e","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1854676220467892699:58979dc5-aaa4-46a5-9843-24a5f695f2b0","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1854930454790742401:2a1f8a10-2ad0-47db-b805-1eb6e056b6bd","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1864859570952376597:83e0d1a2-af5f-4fe6-8fb9-74757b80cd48","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1922604762731532592:24b94a1b-e068-42a9-9a13-d329b078676c","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1952689102060454155:64e6d160-3803-4070-9306-e4273434245f","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1952693600019759212:e9a2f7e3-4ce0-485a-acbc-875cb437b590","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1952715620279042209:59c9a0a1-76b7-431b-835d-1949af917192","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1952753557322506438:b86bfc7f-3211-4840-b212-b6e298fe37bb","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1952791818229145606:9a5ab20a-2c77-4951-a81f-e5de3df1b1c3","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1953411295568368110:07ab07bf-c78f-419d-ac32-cda212918f5e","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1954962381286805835:d2a83f72-7e62-44fc-b7dc-c1100f3c7e63","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1956761870129389863:1402c153-f9ef-48c4-8ef6-9fb6e606bf43","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1957448322538406343:b9c3dd87-4650-4707-b0ee-0703ec237b32","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1968283915220852894:46cc8d88-f693-4a1a-8eca-dc75b7aa6451","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1968284237980917812:649b9f24-f403-4acd-bb47-0a836a12dcae","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1968285689415381450:4861c928-b168-4b0d-bad9-044288ba7860","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1968286145693007960:88aff055-2bc5-46c5-abee-fe1e5336bca9","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1968291300798767361:0504f62e-c741-42a2-b208-3adebbd43ce7","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1968291558106808816:8eef5889-43a1-4421-895a-39ca7f9c060b","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1968306503518953739:448d3330-28b8-46a4-a965-5f811b676dc8","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1968315963960418677:b51b705d-28d4-4751-a057-17f04e6ceaa0","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1968323892369555539:1dfc9bb7-ae27-49ba-b4c2-a1a7a98bab1b","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1968351803537281195:25939bd2-1c27-41c7-aa2c-3404afb5f3e2","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1969024930214748666:57c578a5-262f-489b-adda-a767fd60f637","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1974888985085493638:ce1ff4b2-0a07-490a-b7c7-dab45489780d","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1982786693930381775:263f5c60-becd-470b-9883-17a78adb8926","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1982813361822724248:de132012-898b-42f2-83d7-d2cf9be3bee9","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1982824870191804620:221c196e-3e54-4f6b-be5f-ed6f01229190","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1985335781724975392:5dc0e174-9b93-4e2d-ba86-5a2bcc08ca27","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1985376665409651054:7212541f-a9e4-4a12-9b60-e232398e023f","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1986796093804253670:1ed6ead3-1c8a-4cb3-9e3f-1dd7eb008b9a","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1986796216848728200:99a4c3c9-2baf-4e12-9dff-50a9ba0bf54b","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1986799806044422447:83081319-2a49-4a17-a9c9-8ca8cf3c5ed2","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1986805026627445056:10c05b06-0a21-413d-8559-06ef530ee1e4","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1986811260835369241:6ba10978-0990-4883-b9c3-147e6be6ce8a","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1986828120716935615:6906eb66-8cc1-48b0-a3ff-b60984d35228","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1986852460279787876:d0a3115f-57b2-4e92-a314-869a7456629a","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1986863815837749601:6596751d-1dc4-4d68-8aaf-2d7f3aa5cd27","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1986955684118974728:09501d2b-2cf8-4839-b3aa-10a67faf7384","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1988773805708234964:540a4ea6-3995-4cb5-8c46-cc41b6b7b9e9","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1999103366136262665:75c2cfa4-9294-45f3-8ddf-83d3c1b0330b","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:1999104967051727171:b1082569-6ed0-4141-9fa1-bb5a23bf00cd","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2018015527730319489:15d4d6a9-1b73-47cb-bb68-186b59142838","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2019786173376332209:035f2dea-cd6d-4db8-9e49-bb06e25fb9d1","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2028101596144337276:6451eff3-95b9-44cf-bdcd-207d357580ec","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2028102898073088445:875e19f2-435e-481f-af15-db3d9e4c272d","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2032503589235540264:f0c5e087-df1e-448d-8f84-51bc19f2b953","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2032504978611286455:2cabb05c-82ce-43f0-8b72-343ed7bebe4e","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2033347633075695903:5b3188f0-8e1b-4b83-a298-16398a504f91","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2039474399087349901:1890fa6e-40c9-427e-b2cd-521543a84b50","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2053973567524552823:0ccbb1ae-c598-47a3-9002-8b8538c224d4","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2053973988334825943:fb5a155f-6f8e-4d4a-97ae-9d23dcf7a505","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2053975122717896721:fdf2ec27-4fd4-4c17-9b12-685dfd1d19a0","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2054049738517819832:23484f02-a051-440b-a1f7-ab5d96fb91fd","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2066475969456570400:10642f81-66c3-468d-ac5e-d29536aedbf4","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2066476145009140067:f55bb296-92e7-4e86-b962-e5d841bb2b79","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2066476338454679732:01c3a7ed-dde8-4f76-966e-b0363dc76852","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2066480136355283350:8fd31517-e252-4221-8a1f-d1509d21598b","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2066480973378666785:5a59a932-f15b-48a4-94c5-58f740debdd6","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2066492133192642950:66fd454b-5af6-430d-b2a8-caf35df64b0e","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2066495114067804282:3028b129-3445-41bf-acae-062842e5bd1b","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2066495640188699036:df2b4746-5161-4a2b-99c2-518089bd42f7","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2066496262388535657:7cf19175-6511-40d4-afaf-44cf70881440","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2066502350554931258:99797777-c7bd-4ea9-91e4-4419f8bab3d0","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2066512645650256343:7c7be0f0-b50e-4089-8309-14803d2a57bc","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2066514254333870131:6a0ecf18-bc03-44fc-b0d4-e23a0e7f5521","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2066517258264883637:d4c1eb24-0a16-477b-8b8d-64d611e76575","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2066517654290968888:c55e4f0e-5550-4f32-b9de-9bf312806753","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2066522304532873534:e35e1c2e-0997-4e46-b9b7-6676bb6fcdea","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2066535969415966805:f5fba59e-9f55-455b-be0e-ea4c207455ec","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2066537272066158754:a151add4-30e9-4b2d-8d18-2c2994c1f64a","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2066555067574984882:03e24019-0a52-4aa5-a461-5ef6688d4466","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2066568442887672084:d597508e-04df-4f67-8cac-f11af70c03ae","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2066960606108770630:473ccec0-bd62-407e-b9d4-6b52732e32f6","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2067217650153840952:ff1567b2-c9f9-4f08-8c01-e2e7bb1954ae","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2067278088745177148:8c99a40c-303f-4885-85ef-48a4313d8132","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2067282048793170007:57f68194-68e4-4a57-912a-82a7a50aa2d4","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2068695931281715402:0c1b6f78-c158-46f5-b1fb-582e1d1d4c4d","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2069346707167498711:09c49e73-5f60-4d87-91ab-9218fd0e5a6b","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2069480607571460184:303050b0-3560-41a7-b4c5-dd7957123a40","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2069759793414426967:b79e7fea-6f16-4728-8378-891b38c46f4f","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2070418212966084686:f4472225-f828-47aa-be95-8a7776665cb0","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2072637095135617052:e47981db-b363-4ebc-99ac-677212d7574e","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2079914657297391744:c38dd5f6-ce07-436f-bb14-5be44c495abd","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2082993174407193074:441a3815-6e0a-44ce-83b3-da79b044c2a3","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2088125141335023797:eefd32a1-3f93-4efa-8a97-6c4e41f443fe","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2103141030514016646:a7a6b54a-f6b2-4666-bad0-c0892d63b7fc","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2103142129518485671:5bc63d9a-b7a3-47e3-9da2-47a685a5c174","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2103159138792681924:1bae801b-dd2e-4741-9eff-cc001482ee8b","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2103160113422893494:10714a2c-46cd-496e-a335-011568afe943","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2106583839673921835:f3699170-975c-4f3f-8b92-534348ea4617","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2108916269890392115:245932cc-b91e-4fcd-80bd-1bc11dac1376","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2110151638308831303:119480a2-04a7-4ca7-bca3-6250b26c2b00","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2110616426516013484:036e0478-df2d-4449-aa1d-e7636b5aa4f4","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2111079668140900657:8b976118-8e78-455b-9573-719468239e80","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2111102281814810770:6ec139ef-b607-4252-9a93-4063b3762b3c","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2112902368220287215:f730ae81-aa09-487b-9d1c-337436f579c2","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113208955425984822:d6849bc3-a98e-4a9a-9b10-335399bba83b","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113369468265185763:df22d18c-d768-4319-b3b0-6ebb057176a5","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113574911528575163:cba772d4-08e5-4a69-b9a2-af0111c7aa45","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113580549432303883:6d54450c-8cbc-46ac-96af-5c3cd39f6462","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113613370427380083:d9548f89-9ea4-4e07-809c-1148034956b2","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113613704847601776:c603b0df-4179-45a6-a230-4468d42687d9","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113614179097837868:0079b5e5-683f-409f-8584-ed01a5c7ae93","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113615516954681605:5361aa6a-ae9a-4722-a75e-06093521a168","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113616926308290782:4be137a1-9f8c-4f83-b932-97d9fb59926b","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113617297545855369:a12e4203-2082-4e60-b4f6-9be950a18c41","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113618528251314320:320864df-c35f-41f8-80d2-824ca0ab0893","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113623889268142297:3760f2a6-7100-4afc-b470-3c6e1268775e","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113630450111647960:f2aa8fab-4ba6-43ca-a513-a9245df370c7","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113640569608208652:fca70e99-db1b-44c5-a9bf-4aabac384046","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113647395976392970:b96a9b92-786a-4b9a-b61e-f928413e7d63","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113652282835259707:319cb058-cc01-4d96-a924-1d84bbc42deb","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113699507502281212:7d1c11d6-e114-4af9-a7ee-884b3189d549","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113704726852182312:1454a47b-82b2-4baf-88c2-ccd9b3bcc7e9","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113809852334215294:c3457d94-68ce-4a85-ab5b-41e6c16df4a6","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113944928925499856:5ffe5ded-086a-49e4-a68e-79419b6dbc9a","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2113974097721909358:a4d3fb64-5d61-4e51-8f9c-f991feb5b080","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2114004597140549902:7ce20f40-c66e-4271-b35e-561eb7594cd4","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2114015534278713424:f743cd26-1b10-470f-a6ef-d01c92c9ffc7","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2114034283186639086:5bbd4863-701c-4611-9614-84ad05344170","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2114038207780196468:84aa9fec-251b-4ac5-9742-c90364dbdb54","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2114198575454552223:3f9f77de-58ba-434f-af89-5b9cd4289a97","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2114296889529004200:9f4a203b-42e5-4eac-a760-7e841894382d","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2114360002848669820:a13e385b-2c43-47a1-bbb5-f05caebedbe9","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2114366744433213690:1afb5bb6-8937-41c6-b9ae-33c01c74ff72","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2114417552679948635:da1d8de1-20ec-49cd-94b5-9c3d45dec4f3","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2114530783562236021:2be710b2-67d6-409c-b5db-f26b45ec70ed","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2114673767154585986:f9ae301a-792f-4067-aaf1-5070818e64b0","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2115291798319067389:d5a46cff-c03e-4290-952c-c892dc3be7e4","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2115552466062184645:f4a58239-a680-44fb-820d-3f827b160dfa","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2115743827587916038:93a4cce0-1609-4f49-a0e4-faa012332468","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2115793521936327090:8d1af275-af00-4e85-81fd-83d799cac0b7","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2115825486375100844:25ef1dd4-ae90-4362-892d-4d9b7e65ed54","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2115849276983238904:8c4b51fc-a996-4672-b652-0b536e6dfd50","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2115855275744014841:acc4f468-e23a-4846-bcc6-3d69c46a69f0","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2115943643257463169:36a8b169-424a-4769-af0b-f0ed5f71125f","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2115984362584105052:db93eb62-4271-41b2-af9a-b9eb60bd4dbd","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2116092803876900940:774b6559-58c1-47ec-b51a-5955d99cfa6c","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2116157190264471996:6740f74a-ceee-49bc-a312-f9082f43748c","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2116199729709154719:c76177f0-d6fd-47da-976d-dcad7d78a407","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2116205717829099800:dd4c53f9-3301-4a2e-a12b-2ec7542a787c","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2116226015320322147:3ce4bea4-f911-486c-8043-45e0c330dde5","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2116854019482374599:a8d8735c-e612-4f41-9200-9130972ddf2d","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2116924741911273578:25a61884-aa2d-42f7-b8d2-92c3e8d2ae76","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2116942092211458397:3629b32f-a3b1-4789-9fd8-17696868ebd4","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2117027967096484249:e7c15d4d-8ab9-4d66-ab93-481753b7828e","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2117273604186370536:41b7e38e-bb3c-4cdf-a2b5-6c062da03e63","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2117276213173461179:79d753aa-5987-4f49-99b3-60969a96bffd","quote_policy":"short_quote_link_out"},{"id":"mcp:x_thread:2117640445496840303:720eb1a8-e9ea-4572-9ca6-9587ce4d5e82","quote_policy":"short_quote_link_out"},{"id":"mcp:youtube:LTFLqgeZoHA","quote_policy":"short_quote_link_out"},{"id":"mcp:youtube:RLX9Hy_h2PU","quote_policy":"short_quote_link_out"},{"id":"mcp:youtube:WZ-AHvDkaNk","quote_policy":"short_quote_link_out"},{"id":"mcp:youtube:lecQNg1G8Bg","quote_policy":"short_quote_link_out"},{"id":"mcp:youtube:nC0ZJlDBpbg","quote_policy":"short_quote_link_out"}],"screened_sources":{"by_channel":{"bluesky_thread":28,"linkedin_post":8,"other":0,"podcast":3,"publication":0,"registry":0,"regulatory":0,"x_thread":184,"x_video":0,"youtube":5},"by_evidence_role":{"commentary":228},"count":228,"evidence_window":{"end":"2026-11-03","start":"2023-04-27"},"retrieval_snapshot":"2026-11-04T15:26:26.195797Z","timeline":[{"count":2,"week":"2023-W17"},{"count":4,"week":"2024-W02"},{"count":5,"week":"2024-W03"},{"count":1,"week":"2024-W04"},{"count":1,"week":"2024-W06"},{"count":1,"week":"2024-W07"},{"count":7,"week":"2024-W17"},{"count":1,"week":"2024-W19"},{"count":6,"week":"2024-W21"},{"count":2,"week":"2024-W24"},{"count":5,"week":"2024-W26"},{"count":4,"week":"2024-W45"},{"count":2,"week":"2024-W49"},{"count":1,"week":"2025-W20"},{"count":7,"week":"2025-W32"},{"count":3,"week":"2025-W33"},{"count":1,"week":"2025-W34"},{"count":12,"week":"2025-W38"},{"count":1,"week":"2025-W40"},{"count":1,"week":"2025-W41"},{"count":5,"week":"2025-W44"},{"count":12,"week":"2025-W45"},{"count":1,"week":"2025-W46"},{"count":3,"week":"2025-W50"},{"count":1,"week":"2026-W05"},{"count":1,"week":"2026-W07"},{"count":2,"week":"2026-W09"},{"count":1,"week":"2026-W10"},{"count":2,"week":"2026-W11"},{"count":1,"week":"2026-W12"},{"count":1,"week":"2026-W14"},{"count":1,"week":"2026-W18"},{"count":4,"week":"2026-W20"},{"count":1,"week":"2026-W22"},{"count":31,"week":"2026-W25"},{"count":5,"week":"2026-W26"},{"count":2,"week":"2026-W27"},{"count":1,"week":"2026-W30"},{"count":2,"week":"2026-W31"},{"count":1,"week":"2026-W33"},{"count":5,"week":"2026-W39"},{"count":1,"week":"2026-W40"},{"count":1,"week":"2026-W41"},{"count":5,"week":"2026-W42"},{"count":45,"week":"2026-W43"},{"count":29,"week":"2026-W44"},{"count":4,"week":"2026-W45"}],"undated_sources":0}},"taxonomy":{"biomarkers":{"reason":"No structured, checked-in biomarker mapping for this trial.","status":"unmapped"},"conferences":{"reason":"No conferences in source metadata.","status":"none"},"drugs":[{"reason":"Unmapped registry intervention: eli-002 7p","status":"unmapped"}],"indications":[{"reason":"Unmapped registry condition: Pancreatic Ductal Adenocarcinoma","status":"unmapped"},{"brand_names":{"reason":"Indication, not a drug.","status":"not_applicable"},"label":"Colorectal cancer","slug":"colorectal-cancer"},{"reason":"Unmapped registry condition: KRAS G12D","status":"unmapped"},{"reason":"Unmapped registry condition: KRAS G12R","status":"unmapped"},{"reason":"Unmapped registry condition: KRAS G12V","status":"unmapped"},{"reason":"Unmapped registry condition: KRAS G12A","status":"unmapped"},{"reason":"Unmapped registry condition: KRAS G12C","status":"unmapped"},{"reason":"Unmapped registry condition: KRAS G12S","status":"unmapped"},{"reason":"Unmapped registry condition: KRAS G13D","status":"unmapped"},{"reason":"Unmapped registry condition: NRAS G12D","status":"unmapped"},{"reason":"Unmapped registry condition: NRAS G12R","status":"unmapped"},{"reason":"Unmapped registry condition: NRAS G12V","status":"unmapped"},{"reason":"Unmapped registry condition: NRAS G12C","status":"unmapped"},{"reason":"Unmapped registry condition: NRAS G12S","status":"unmapped"}],"line_of_therapy":{"reason":"No structured, checked-in line-of-therapy mapping for this trial.","status":"unmapped"},"therapeutic_area":["oncology"]},"trial":{"acronym":"AMPLIFY-7P","aliases":["AMPLIFY-7P","A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors","First in Human Phase 1/2 Trial of ELI-002 7P Immunotherapy as Treatment for Subjects With Kirsten Rat Sarcoma (KRAS)/Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors"],"brief_title":"A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors","collaborators":{"reason":"Not present in the acquired registry snapshot.","status":"unavailable"},"conditions":["Pancreatic Ductal Adenocarcinoma","Colorectal Cancer","KRAS G12D","KRAS G12R","KRAS G12V","KRAS G12A","KRAS G12C","KRAS G12S","KRAS G13D","NRAS G12D","NRAS G12R","NRAS G12V","NRAS G12C","NRAS G12S"],"display_condition":"KRAS/NRAS mutated pancreatic cancer and other solid tumors","display_interventions":[["ELI-002 7P"]],"enrollment":{"count":158,"type":"ACTUAL"},"interventions":[{"name":"ELI-002 7P","synonyms":{"reason":"Not present in the acquired registry snapshot.","status":"unavailable"},"type":"DRUG"}],"nct_id":"NCT05726864","official_title":"First in Human Phase 1/2 Trial of ELI-002 7P Immunotherapy as Treatment for Subjects With Kirsten Rat Sarcoma (KRAS)/Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors","overall_status":"ACTIVE_NOT_RECRUITING","phase":["PHASE1","PHASE2"],"primary_completion_date":{"date":"2026-04-20","type":"ACTUAL"},"primary_endpoints":[{"description":"Safety will be assessed by the incidence of adverse events (AEs) and clinically significant changes in laboratory tests and vital signs","measure":"Phase 1: Evaluate the safety of ELI-002 7P","timeFrame":"28 days after the first dose of ELI-002 7P"},{"description":"DFS is assessed by the investigator through computed tomography (CT) imaging or magnetic resonance imaging (MRI) with contrast and using iRECIST criteria","measure":"Phase 2: Compare ELI-002 7P versus standard of care (SOC; observation) in DFS (disease free survival)","timeFrame":"After the last radiographic assessment at Visit 26 (Week 150)"}],"registered_date":{"date":"2023-02-14","type":"ACTUAL"},"registry_last_updated":"2026-07-10","registry_url":"https://clinicaltrials.gov/study/NCT05726864","short_name":"AMPLIFY-7P","short_name_basis":"registry_acronym","sponsor":"Elicio Therapeutics","start_date":{"date":"2023-04-14","type":"ACTUAL"},"study_design":"interventional, randomized, sequential, phase1, phase2","study_ids":[{"id":"ELI-002-201","type":"sponsor_study_id"}],"study_type":"INTERVENTIONAL"}}}